Nektar Therapeutics | Marktkapitalisierung

Aktienkurs
65.48
Täglich Wechseln
9.48 16.93%
Monatlich
68.89%
Jährlich
497.17%
Q1 Prognose
1.21




Marktkapitalisierung Veränderung Datum
Agios Pharmaceuticals USD 2.33B 402M 2025-09
ALKERMES USD 4.95B 235M 2025-09
Alterity Therapeutics Limited AUD 11M 5M 2023-06
Amgen USD 201.45B 25.2B 2026-02
Baxter International USD 11.7B 3.84B 2025-09
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 27.01B 1.19B 2026-02
Bristol-Myers Squibb USD 123.58B 13.77B 2026-02
Cara Therapeutics USD 46M 23M 2025-06
Cipla INR 1.22T 6.47B 2025-12
Dr.Reddys Laboratories INR 1.06T 39.78B 2025-12
Eisai JPY 1.29T 163.66B 2026-02
Eli Lilly USD 1.01T 3.37B 2026-02
Esperion Therapeutics USD 340M 235M 2023-12
Exelixis USD 12.27B 523M 2026-02
Gilead Sciences USD 183.59B 31.31B 2026-02
GlaxoSmithKline GBP 87.33B 12.98B 2026-02
Grifols EUR 6.77B 773M 2025-09
Halozyme Therapeutics USD 8.58B 2.17B 2025-09
Incyte USD 22.46B 3.07B 2026-02
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
Ironwood Pharmaceuticals USD 213M 97M 2025-09
MacroGenics USD 114M 8M 2026-02
Merck USD 300.37B 39.11B 2026-02
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 13.7B 221M 2026-02
Novartis USD 265.66B 9.48B 2025-09
Pfizer USD 152.89B 11.32B 2026-02
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.02B 336M 2025-09
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Xencor USD 837M 278M 2025-09


Nektar Therapeutics Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.